Unilateral optic disc papilloedema following administration of carboplatin chemotherapy for ovarian carcinoma

8Citations
Citations of this article
26Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A 48-year-old woman with a positive BRCA1 gene mutation was diagnosed with stage 3b high-grade ovarian endometrioid carcinoma. She was treated with adjuvant carboplatin at a dose of 740 mg (AUC 6) in 3-weekly cycles. Five days after her fifth cycle of carboplatin, she awoke with new-onset blurred vision in her left eye. An ophthalmology review showed left-sided disc oedema with normal optic nerve function tests and 6/24 visual acuity. A CT scan of the head and orbits was performed which showed no evidence of metastasis or raised intracranial pressure. An autoimmune screen was performed which did not reveal any explanation for her visual symptoms. Fundus fluorescein angiography showed bilateral intense late disc leakage with no evidence of vasculitis. Her chemotherapy was stopped in view of a radiological and biochemical remission and her visual symptoms were monitored. She was also started on a tapering dose of prednisolone 40 mg daily. Five months after the initial review, she has developed left optic disc atrophy with 6/18 visual acuity, while the right eye remains asymptomatic. The diagnosis was felt to be that of carboplatin-induced unilateral disc oedema, a very rare side effect of this chemotherapy. © 2014 S. Karger AG, Basel.

Cite

CITATION STYLE

APA

Lewis, P., Waqar, S., Yiannakis, D., & Raman, V. (2014). Unilateral optic disc papilloedema following administration of carboplatin chemotherapy for ovarian carcinoma. Case Reports in Oncology, 7(1), 29–32. https://doi.org/10.1159/000357912

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free